Globus Medical, Inc. (GMED) Social Stream
GLOBUS MEDICAL INC (GMED) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering GMED.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 11 | $100 | $55.001 | $85.636 | $53.84 | 59.06% |
| 2021-11-16 | 11 | $100 | $55 | $85.636 | $53.84 | 59.06% |
| 2021-12-10 | 11 | $100 | $55 | $85.166 | $53.84 | 58.18% |
| 2021-12-13 | 11 | $100 | $80 | $87.25 | $53.84 | 62.05% |
| 2022-01-04 | 11 | $100 | $80 | $87.916 | $53.84 | 63.29% |
| 2022-01-07 | 11 | $100 | $80 | $88.083 | $53.84 | 63.6% |
| 2022-01-25 | 11 | $100 | $72 | $87.416 | $53.84 | 62.36% |
| 2022-02-17 | 11 | $100 | $70 | $86.5 | $53.84 | 60.66% |
| 2022-02-18 | 11 | $100 | $70 | $85.583 | $53.84 | 58.96% |
| 2022-02-22 | 12 | $100 | $70 | $84.916 | $53.84 | 57.72% |
| 2022-04-11 | 12 | $100 | $70 | $84.538 | $53.84 | 57.02% |
| 2022-04-22 | 10 | $100 | $70 | $85.384 | $53.84 | 58.59% |
| 2022-05-10 | 10 | $100 | $65 | $83.846 | $53.84 | 55.73% |
| 2022-05-11 | 10 | $100 | $65 | $82.923 | $53.84 | 54.02% |
| 2022-05-27 | 10 | $100 | $65 | $81 | $53.84 | 50.45% |
| 2022-06-02 | 10 | $100 | $65 | $80.384 | $53.84 | 49.3% |
| 2022-07-20 | 9 | $100 | $62 | $77.833 | $53.84 | 44.56% |
| 2022-08-05 | 9 | $100 | $62 | $74.9 | $53.84 | 39.12% |
| 2022-09-17 | 9 | $100 | $62 | $73.4 | $53.84 | 36.33% |
| 2022-10-17 | 10 | $100 | $65 | $73.909 | $53.84 | 37.28% |
| 2022-10-19 | 11 | $100 | $65 | $73.909 | $53.84 | 37.28% |
| 2022-10-30 | 10 | $80 | $65 | $71.091 | $53.84 | 32.04% |
| 2022-11-09 | 10 | $80 | $65 | $71.363 | $53.84 | 32.55% |
| 2022-11-18 | 10 | $80 | $65 | $71.545 | $53.84 | 32.88% |
| 2022-12-12 | 9 | $82 | $65 | $71.9 | $53.84 | 33.54% |
| 2022-12-20 | 9 | $85 | $65 | $73 | $53.84 | 35.59% |
| 2023-01-03 | 9 | $85 | $65 | $74.3 | $53.84 | 38% |
| 2023-01-04 | 9 | $85 | $65 | $75.6 | $53.84 | 40.42% |
| 2023-02-08 | 9 | $85 | $65 | $76.6 | $53.84 | 42.27% |
| 2023-02-09 | 8 | $85 | $65 | $76.6 | $53.84 | 42.27% |
| 2023-02-10 | 9 | $83 | $65 | $75.1 | $53.84 | 39.49% |
| 2023-02-14 | 9 | $82 | $63 | $73.1 | $53.84 | 35.77% |
| 2023-02-15 | 12 | $82 | $63 | $71.909 | $53.84 | 33.56% |
| 2023-02-22 | 13 | $82 | $63 | $70.181 | $53.84 | 30.35% |
| 2023-05-05 | 13 | $75 | $61 | $66.727 | $53.84 | 23.94% |
| 2023-05-19 | 13 | $75 | $61 | $66.727 | $53.84 | 23.94% |
| 2023-06-11 | 14 | $75 | $60 | $66.363 | $53.84 | 23.26% |
| 2023-07-19 | 14 | $75 | $60 | $66.727 | $53.84 | 23.94% |
| 2023-08-04 | 14 | $75 | $60 | $66.181 | $53.84 | 22.92% |
| 2023-08-13 | 14 | $77 | $60 | $66.545 | $53.84 | 23.6% |
| 2023-09-19 | 14 | $77 | $58 | $65.727 | $53.84 | 22.08% |
| 2023-10-13 | 14 | $86 | $58 | $65.909 | $53.84 | 22.42% |
| 2023-10-21 | 13 | $86 | $58 | $66.3 | $53.84 | 23.14% |
| 2023-11-03 | 13 | $86 | $55 | $65.5 | $53.84 | 21.66% |
| 2023-11-08 | 13 | $86 | $53 | $64.3 | $53.84 | 19.43% |
| 2023-11-10 | 13 | $86 | $53 | $63.3 | $53.84 | 17.57% |
| 2023-11-22 | 13 | $86 | $53 | $62.6 | $53.84 | 16.27% |
| 2023-12-04 | 14 | $86 | $53 | $63.272 | $53.84 | 17.52% |
| 2023-12-27 | 15 | $86 | $53 | $64.333 | $53.84 | 19.49% |
The Trend in the Analyst Price Target
GMED's average price target has moved down $9.97 over the prior 51 weeks.
GMED reports an average of 22.6% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-15 | 13 | 75 | 61 | 66.727 | 52.51 | 27.07% |
| 2023-07-19 | 14 | 75 | 60 | 66.727 | 61.35 | 8.76% |
| 2023-10-19 | 13 | 86 | 58 | 66.300 | 51.40 | 28.99% |
| 2023-11-03 | 13 | 86 | 55 | 65.500 | 46.99 | 39.39% |
| 2023-11-15 | 13 | 86 | 53 | 62.600 | 45.81 | 36.65% |
GMED Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 5 | 1 | 8 | 0 | 0 | 15 |
The Trend in the Broker Recommendations
GMED's average broker recommendation rating worsened by 0.76 over the prior 21 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GMED as an investment opportunity.
- In terms of how GLOBUS MEDICAL INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 4409.31% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, GLOBUS MEDICAL INC's average analyst price target is greater than 4359.07% of them.
- GMED has a lower variance in analysts' estimates than -1456.34% of Healthcare stocks.
- GLOBUS MEDICAL INC's upside potential (average analyst target price relative to current price) is higher than 2125.18% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to GLOBUS MEDICAL INC are IART, MMSI, and HAE.
View All Top Stocks by Price Target
Make investment decisions regarding GMED using the data that counts. Try POWR Ratings for free.